Pharmacologic control of gastric acid secretion in peptic ulcer.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001570:Benzodiazepinones / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005744:Gastric Acid / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D009853:Omeprazole; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D010890:Pirenzepine; D011453:Prostaglandins / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D000929:Antidepressive Agents, Tricyclic; D001562:Benzimidazoles; D001570:Benzodiazepinones; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D011453:Prostaglandins; D010890:Pirenzepine; D009853:Omeprazole